speb/financial-data huggingface dataset:
IVDA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -214303.00
IVDA balance_sheet (quarterly, 2025-09-30) — Working Capital: 3904486.00
IVDA income_statement (annual, 2025-12-31) — +Operating Expense: 4499768.00
IVDA income_statement (quarterly, 2025-12-31) — +Operating Expense: 1667289.00
IVDA income_statement (annual, 2025-12-31) — +Total Revenue: 5280312.00
IVDA income_statement (quarterly, 2025-12-31) — +Total Revenue: 626042.00
IVDA balance_sheet (annual, 2025-12-31) — Accounts Payable: 938560.00
IVDA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 938560.00
IVDA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 256699.00
IVDA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 256699.00
IVDA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 61403700.00
IVDA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 61403700.00
IVDA income_statement (annual, 2025-12-31) — Basic Average Shares: 3640615.00
IVDA income_statement (annual, 2025-12-31) — Basic EPS: -0.88
IVDA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2658300.00
IVDA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3331276.00
IVDA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 156536.00
IVDA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 156536.00
IVDA balance_sheet (annual, 2025-12-31) — Capital Stock: 59.00
IVDA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 59.00
IVDA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5156252.00
IVDA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5156252.00
IVDA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5156252.00
IVDA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5156252.00
IVDA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4558106.00
IVDA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2175157.00
IVDA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IVDA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IVDA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2027501.00
IVDA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -252421.00
IVDA cash_flow (annual, 2025-12-31) — Change In Inventory: -87838.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Inventory: 11558.00
IVDA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 151002.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 30919.00
IVDA cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -26132.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -10876.00
IVDA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 390357.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 120798.00
IVDA cash_flow (annual, 2025-12-31) — Change In Payable: -810298.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Payable: -302342.00
IVDA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -810298.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -302342.00
IVDA cash_flow (annual, 2025-12-31) — Change In Receivables: 1020936.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1067387.00
IVDA cash_flow (annual, 2025-12-31) — Change In Working Capital: 638027.00
IVDA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 917444.00
IVDA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1020936.00
IVDA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 1067387.00
IVDA cash_flow (annual, 2025-12-31) — Changes In Cash: 2530605.00
IVDA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1922736.00
IVDA balance_sheet (annual, 2025-12-31) — Common Stock: 59.00
IVDA balance_sheet (quarterly, 2025-12-31) — Common Stock: 59.00
IVDA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4779762.00
IVDA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4779762.00
IVDA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 4930394.00
IVDA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2224048.00
IVDA income_statement (annual, 2025-12-31) — Cost Of Revenue: 4007440.00
IVDA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 603428.00
IVDA balance_sheet (annual, 2025-12-31) — Current Assets: 6155559.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Assets: 6155559.00
IVDA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 41632.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 41632.00
IVDA balance_sheet (annual, 2025-12-31) — Current Debt: 287100.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Debt: 287100.00
IVDA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 328732.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 328732.00
IVDA balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 116951.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 116951.00
IVDA balance_sheet (annual, 2025-12-31) — Current Liabilities: 1267292.00
IVDA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1267292.00
IVDA cash_flow (annual, 2025-12-31) — Depreciation: 21584.00
IVDA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 21584.00
IVDA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5522.00
IVDA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 21584.00
IVDA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5522.00
IVDA income_statement (annual, 2025-12-31) — Diluted Average Shares: 3640615.00
IVDA income_statement (annual, 2025-12-31) — Diluted EPS: -0.88
IVDA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1618887.00
IVDA income_statement (annual, 2025-12-31) — EBIT: -3131119.00
IVDA income_statement (quarterly, 2025-12-31) — EBIT: -1611824.00
IVDA income_statement (annual, 2025-12-31) — EBITDA: -3109535.00
IVDA income_statement (quarterly, 2025-12-31) — EBITDA: -1606302.00
IVDA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 31041.00
IVDA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -34066.00
IVDA cash_flow (annual, 2025-12-31) — End Cash Position: 5219946.00
IVDA cash_flow (quarterly, 2025-12-31) — End Cash Position: 5219946.00
IVDA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 4558106.00
IVDA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2175157.00
IVDA cash_flow (annual, 2025-12-31) — Free Cash Flow: -2027501.00
IVDA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -252421.00
IVDA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -249168.00
IVDA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -249168.00
IVDA income_statement (annual, 2025-12-31) — General And Administrative Expense: 4328968.00
IVDA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1606739.00
IVDA balance_sheet (annual, 2025-12-31) — Gross PPE: 196036.00
IVDA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 196036.00
IVDA income_statement (annual, 2025-12-31) — Gross Profit: 1272872.00
IVDA income_statement (quarterly, 2025-12-31) — Gross Profit: 22614.00
IVDA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 28240.00
IVDA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 15806.00
IVDA income_statement (annual, 2025-12-31) — Interest Expense: 36509.00
IVDA income_statement (quarterly, 2025-12-31) — Interest Expense: 7022.00
IVDA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 36509.00
IVDA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 7022.00
IVDA income_statement (annual, 2025-12-31) — Interest Income: 61937.00
IVDA income_statement (quarterly, 2025-12-31) — Interest Income: 31136.00
IVDA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 61937.00
IVDA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 31136.00
IVDA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 25374.00
IVDA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 10642.00
IVDA balance_sheet (annual, 2025-12-31) — Inventory: 235958.00
IVDA balance_sheet (quarterly, 2025-12-31) — Inventory: 235958.00
IVDA balance_sheet (annual, 2025-12-31) — Invested Capital: 5332694.00
IVDA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5332694.00
IVDA cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
IVDA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
IVDA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 4930394.00
IVDA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2224048.00
IVDA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 651572.00
IVDA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 578943.00
IVDA balance_sheet (annual, 2025-12-31) — Line Of Credit: 159500.00
IVDA balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 159500.00
IVDA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 114904.00
IVDA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 114904.00
IVDA balance_sheet (annual, 2025-12-31) — Long Term Debt: 265832.00
IVDA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 265832.00
IVDA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 380736.00
IVDA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 380736.00
IVDA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 4930394.00
IVDA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 2224048.00
IVDA income_statement (annual, 2025-12-31) — Net Income: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1618887.00
IVDA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -3198112.00
IVDA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1618887.00
IVDA income_statement (annual, 2025-12-31) — Net Interest Income: 25428.00
IVDA income_statement (quarterly, 2025-12-31) — Net Interest Income: 24114.00
IVDA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -372288.00
IVDA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -48891.00
IVDA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -104763.00
IVDA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -44257.00
IVDA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 25428.00
IVDA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 24114.00
IVDA balance_sheet (annual, 2025-12-31) — Net PPE: 196036.00
IVDA balance_sheet (quarterly, 2025-12-31) — Net PPE: 196036.00
IVDA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
IVDA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
IVDA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -267525.00
IVDA cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -4634.00
IVDA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 4779762.00
IVDA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 4779762.00
IVDA income_statement (annual, 2025-12-31) — Normalized EBITDA: -3109535.00
IVDA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1606302.00
IVDA income_statement (annual, 2025-12-31) — Normalized Income: -3198112.00
IVDA income_statement (quarterly, 2025-12-31) — Normalized Income: -1618887.00
IVDA cash_flow (annual, 2025-12-31) — Operating Cash Flow: -2027501.00
IVDA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -252421.00
IVDA income_statement (annual, 2025-12-31) — Operating Income: -3226896.00
IVDA income_statement (quarterly, 2025-12-31) — Operating Income: -1644675.00
IVDA income_statement (annual, 2025-12-31) — Operating Revenue: 5280312.00
IVDA income_statement (quarterly, 2025-12-31) — Operating Revenue: 626042.00
IVDA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5879741.00
IVDA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5879741.00
IVDA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 127600.00
IVDA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 127600.00
IVDA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -249168.00
IVDA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -249168.00
IVDA income_statement (annual, 2025-12-31) — Other Gand A: 4328968.00
IVDA income_statement (quarterly, 2025-12-31) — Other Gand A: 1606739.00
IVDA income_statement (annual, 2025-12-31) — Other Income Expense: 33840.00
IVDA income_statement (quarterly, 2025-12-31) — Other Income Expense: 1715.00
IVDA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 135000.00
IVDA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 67500.00
IVDA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 76195.00
IVDA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 76195.00
IVDA income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 33840.00
IVDA income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1715.00
IVDA balance_sheet (annual, 2025-12-31) — Other Properties: 196036.00
IVDA balance_sheet (quarterly, 2025-12-31) — Other Properties: 196036.00
IVDA balance_sheet (annual, 2025-12-31) — Payables: 938560.00
IVDA balance_sheet (quarterly, 2025-12-31) — Payables: 938560.00
IVDA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 938560.00
IVDA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 938560.00
IVDA balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
IVDA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IVDA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 326005.00
IVDA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 326005.00
IVDA income_statement (annual, 2025-12-31) — Pretax Income: -3167628.00
IVDA income_statement (quarterly, 2025-12-31) — Pretax Income: -1618846.00
IVDA cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
IVDA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
IVDA balance_sheet (annual, 2025-12-31) — Receivables: 256699.00
IVDA balance_sheet (quarterly, 2025-12-31) — Receivables: 256699.00
IVDA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4007440.00
IVDA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 603428.00
IVDA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 21584.00
IVDA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5522.00
IVDA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -919097.00
IVDA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -583577.00
IVDA income_statement (annual, 2025-12-31) — Research And Development: 170800.00
IVDA income_statement (quarterly, 2025-12-31) — Research And Development: 60550.00
IVDA balance_sheet (annual, 2025-12-31) — Restricted Cash: 63694.00
IVDA balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 63694.00
IVDA balance_sheet (annual, 2025-12-31) — Retained Earnings: -56374829.00
IVDA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -56374829.00
IVDA income_statement (annual, 2025-12-31) — Selling General And Administration: 4328968.00
IVDA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1606739.00
IVDA balance_sheet (annual, 2025-12-31) — Share Issued: 5879741.00
IVDA balance_sheet (quarterly, 2025-12-31) — Share Issued: 5879741.00
IVDA cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 651572.00
IVDA cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 578943.00
IVDA cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -919097.00
IVDA cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -583577.00
IVDA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 376000.00
IVDA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4779762.00
IVDA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4779762.00
IVDA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 4779762.00
IVDA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 4779762.00
IVDA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (annual, 2025-12-31) — Tax Provision: 30484.00
IVDA income_statement (quarterly, 2025-12-31) — Tax Provision: 41.00
IVDA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IVDA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
IVDA balance_sheet (annual, 2025-12-31) — Total Assets: 6427790.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Assets: 6427790.00
IVDA balance_sheet (annual, 2025-12-31) — Total Capitalization: 5045594.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5045594.00
IVDA balance_sheet (annual, 2025-12-31) — Total Debt: 709468.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Debt: 709468.00
IVDA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4779762.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4779762.00
IVDA income_statement (annual, 2025-12-31) — Total Expenses: 8507208.00
IVDA income_statement (quarterly, 2025-12-31) — Total Expenses: 2270717.00
IVDA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1648028.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1648028.00
IVDA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 272231.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 272231.00
IVDA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 380736.00
IVDA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 380736.00
IVDA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -3226896.00
IVDA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1644675.00
IVDA balance_sheet (annual, 2025-12-31) — Working Capital: 4888267.00
IVDA balance_sheet (quarterly, 2025-12-31) — Working Capital: 4888267.00
IVDA income_statement (quarterly, 2026-03-31) — +Operating Expense: 1060910.00
IVDA income_statement (quarterly, 2026-03-31) — +Total Revenue: 1494174.00
IVDA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 876327.00
IVDA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 745311.00
IVDA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 63040326.00
IVDA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8927360.00
IVDA income_statement (quarterly, 2026-03-31) — Basic EPS: -0.06
IVDA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5219946.00
IVDA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 147732.00
IVDA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 117.00
IVDA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5632622.00
IVDA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5632622.00
IVDA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1426439.00
IVDA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
IVDA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -927120.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Inventory: -12016.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -452748.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -8804.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -3234.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Payable: 553253.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 553253.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -508612.00
IVDA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -432161.00
IVDA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -508612.00
IVDA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 499319.00
IVDA balance_sheet (quarterly, 2026-03-31) — Common Stock: 117.00
IVDA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5864259.00
IVDA cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1624684.00
IVDA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 998966.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 302331.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Assets: 7525946.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 42898.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Debt: 125184.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 168082.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 120185.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 313155.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 313155.00
IVDA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1659895.00
IVDA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5872.00
IVDA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5872.00
IVDA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8927360.00
IVDA income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.06
IVDA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — EBIT: -527225.00
IVDA income_statement (quarterly, 2026-03-31) — EBITDA: -521353.00
IVDA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -24155.00
IVDA cash_flow (quarterly, 2026-03-31) — End Cash Position: 5695110.00
IVDA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1426439.00
IVDA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -927120.00
IVDA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -268524.00
IVDA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1030910.00
IVDA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 179552.00
IVDA income_statement (quarterly, 2026-03-31) — Gross Profit: 495208.00
IVDA cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
IVDA income_statement (quarterly, 2026-03-31) — Interest Expense: 5606.00
IVDA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5606.00
IVDA income_statement (quarterly, 2026-03-31) — Interest Income: 32336.00
IVDA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 32336.00
IVDA cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 2525.00
IVDA balance_sheet (quarterly, 2026-03-31) — Inventory: 247974.00
IVDA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6218946.00
IVDA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
IVDA cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1624684.00
IVDA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
IVDA balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 0.00
IVDA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 104834.00
IVDA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 229503.00
IVDA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 334337.00
IVDA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1624684.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -532831.00
IVDA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -532831.00
IVDA income_statement (quarterly, 2026-03-31) — Net Interest Income: 26730.00
IVDA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -198245.00
IVDA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -38745.00
IVDA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 26730.00
IVDA balance_sheet (quarterly, 2026-03-31) — Net PPE: 179552.00
IVDA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
IVDA cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -159500.00
IVDA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5864259.00
IVDA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -521353.00
IVDA income_statement (quarterly, 2026-03-31) — Normalized Income: -532831.00
IVDA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -927120.00
IVDA income_statement (quarterly, 2026-03-31) — Operating Income: -565702.00
IVDA income_statement (quarterly, 2026-03-31) — Operating Revenue: 1494174.00
IVDA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11594027.00
IVDA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 717366.00
IVDA balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 125184.00
IVDA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -268524.00
IVDA income_statement (quarterly, 2026-03-31) — Other Gand A: 1030910.00
IVDA income_statement (quarterly, 2026-03-31) — Other Income Expense: 6141.00
IVDA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 152993.00
IVDA income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6141.00
IVDA balance_sheet (quarterly, 2026-03-31) — Other Properties: 179552.00
IVDA balance_sheet (quarterly, 2026-03-31) — Payables: 876327.00
IVDA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1178658.00
IVDA balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IVDA income_statement (quarterly, 2026-03-31) — Pretax Income: -532831.00
IVDA cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 20000.00
IVDA balance_sheet (quarterly, 2026-03-31) — Receivables: 745311.00
IVDA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 998966.00
IVDA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5872.00
IVDA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -159500.00
IVDA income_statement (quarterly, 2026-03-31) — Research And Development: 30000.00
IVDA balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 62488.00
IVDA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -56907660.00
IVDA cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
IVDA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1030910.00
IVDA balance_sheet (quarterly, 2026-03-31) — Share Issued: 11594027.00
IVDA cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
IVDA cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -159500.00
IVDA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12000.00
IVDA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5864259.00
IVDA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5864259.00
IVDA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Assets: 7858491.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6093762.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Debt: 502419.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5864259.00
IVDA income_statement (quarterly, 2026-03-31) — Total Expenses: 2059876.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1994232.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 332545.00
IVDA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 334337.00
IVDA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -565702.00
IVDA balance_sheet (quarterly, 2026-03-31) — Working Capital: 5866051.00
IVF income_statement (annual, 2021-12-31) — +Operating Expense: 9231588.00
IVF income_statement (annual, 2021-12-31) — +Total Revenue: 4160116.00
IVF balance_sheet (annual, 2021-12-31) — Accounts Payable: 443422.00
IVF balance_sheet (annual, 2021-12-31) — Accounts Receivable: 50470.00
IVF balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -78208.00
IVF balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 46200509.00
IVF cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
IVF income_statement (annual, 2021-12-31) — Basic Average Shares: 414.00
IVF income_statement (annual, 2021-12-31) — Basic EPS: -16074.73
IVF cash_flow (annual, 2021-12-31) — Beginning Cash Position: 10097760.00
IVF cash_flow (annual, 2021-12-31) — Capital Expenditure: -454649.00
IVF balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 2123550.00
IVF balance_sheet (annual, 2021-12-31) — Capital Stock: 1193.00
IVF balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 5684871.00
IVF balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 5684871.00
IVF balance_sheet (annual, 2021-12-31) — Cash Financial: 5684871.00
IVF cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 3770537.00
IVF cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -2153512.00
IVF cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: -6029914.00
IVF cash_flow (annual, 2021-12-31) — Change In Account Payable: 114495.00
IVF cash_flow (annual, 2021-12-31) — Change In Accrued Expense: 20921.00
IVF cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -392.00
IVF cash_flow (annual, 2021-12-31) — Change In Interest Payable: 20921.00
IVF cash_flow (annual, 2021-12-31) — Change In Inventory: -22401.00
IVF cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -53846.00
IVF cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -3511166.00
IVF cash_flow (annual, 2021-12-31) — Change In Payable: 114103.00
IVF cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 135024.00
IVF cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: -124811.00
IVF cash_flow (annual, 2021-12-31) — Change In Receivables: -28771.00
IVF cash_flow (annual, 2021-12-31) — Change In Tax Payable: -392.00
IVF cash_flow (annual, 2021-12-31) — Change In Working Capital: -3605971.00
IVF cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -28771.00
IVF cash_flow (annual, 2021-12-31) — Changes In Cash: -4412889.00
IVF balance_sheet (annual, 2021-12-31) — Common Stock: 1193.00
IVF balance_sheet (annual, 2021-12-31) — Common Stock Equity: 7310680.00
IVF cash_flow (annual, 2021-12-31) — Common Stock Issuance: 3650697.00
IVF income_statement (annual, 2021-12-31) — Cost Of Revenue: 145052.00
IVF balance_sheet (annual, 2021-12-31) — Current Assets: 6305865.00
IVF balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 221993.00
IVF balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 221993.00
IVF balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 5900.00
IVF balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 5900.00
IVF balance_sheet (annual, 2021-12-31) — Current Liabilities: 1253004.00
IVF balance_sheet (annual, 2021-12-31) — Current Notes Payable: 0.00
IVF cash_flow (annual, 2021-12-31) — Depreciation: 166082.00
IVF cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 166082.00
IVF cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 166082.00
IVF income_statement (annual, 2021-12-31) — Diluted Average Shares: 414.00
IVF income_statement (annual, 2021-12-31) — Diluted EPS: -16074.73
IVF income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -6654940.00
IVF income_statement (annual, 2021-12-31) — EBIT: -5384817.00
IVF income_statement (annual, 2021-12-31) — EBITDA: -5218735.00
IVF income_statement (annual, 2021-12-31) — Earnings From Equity Interest: -327542.00
IVF cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 327542.00
IVF cash_flow (annual, 2021-12-31) — End Cash Position: 5684871.00
IVF cash_flow (annual, 2021-12-31) — Financing Cash Flow: 3770537.00
IVF balance_sheet (annual, 2021-12-31) — Finished Goods: 220168.00
IVF cash_flow (annual, 2021-12-31) — Free Cash Flow: -6484563.00
IVF income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -3534.00
IVF balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 132093.00
IVF balance_sheet (annual, 2021-12-31) — Gross PPE: 2616696.00
IVF income_statement (annual, 2021-12-31) — Gross Profit: 4015064.00
IVF cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 3307.00
IVF balance_sheet (annual, 2021-12-31) — Income Tax Payable: 0.00
IVF income_statement (annual, 2021-12-31) — Interest Expense: 1265359.00
IVF income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 1265359.00
IVF income_statement (annual, 2021-12-31) — Interest Income: 3657.00
IVF income_statement (annual, 2021-12-31) — Interest Income Non Operating: 3657.00
IVF cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 52603.00
IVF balance_sheet (annual, 2021-12-31) — Inventory: 287773.00
IVF balance_sheet (annual, 2021-12-31) — Invested Capital: 7310680.00
IVF cash_flow (annual, 2021-12-31) — Investing Cash Flow: -2153512.00
IVF balance_sheet (annual, 2021-12-31) — Investments And Advances: 1489934.00
IVF balance_sheet (annual, 2021-12-31) — Investmentsin Joint Venturesat Cost: 1489934.00
IVF cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 3650697.00
IVF cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
IVF balance_sheet (annual, 2021-12-31) — Leases: 96817.00
IVF balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 1901557.00
IVF balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 1901557.00
IVF cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
IVF cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -250000.00
IVF balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 1489934.00
IVF balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 74891.00
IVF cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -1698863.00
IVF cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 3650697.00
IVF income_statement (annual, 2021-12-31) — Net Income: -6654940.00
IVF income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -6654940.00
IVF income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -6654940.00
IVF income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -6654940.00
IVF income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -6654940.00
IVF cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -6654940.00
IVF income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -6654940.00
IVF cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -38939.00
IVF income_statement (annual, 2021-12-31) — Net Interest Income: -1261702.00
IVF cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -250000.00
IVF cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -250000.00
IVF income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -1261702.00
IVF balance_sheet (annual, 2021-12-31) — Net PPE: 2538488.00
IVF cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -415710.00
IVF cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -250000.00
IVF balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 7178587.00
IVF balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 1139.00
IVF balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 0.00
IVF balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 1139.00
IVF income_statement (annual, 2021-12-31) — Normalized EBITDA: -5374327.00
IVF income_statement (annual, 2021-12-31) — Normalized Income: -6768522.16
IVF cash_flow (annual, 2021-12-31) — Operating Cash Flow: -6029914.00
IVF cash_flow (annual, 2021-12-31) — Operating Gains Losses: 168416.00
IVF income_statement (annual, 2021-12-31) — Operating Income: -5216524.00
IVF income_statement (annual, 2021-12-31) — Operating Revenue: 4160116.00
IVF balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 414.00
IVF balance_sheet (annual, 2021-12-31) — Other Current Assets: 282751.00
IVF income_statement (annual, 2021-12-31) — Other Income Expense: -171950.00
IVF balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 132093.00
IVF cash_flow (annual, 2021-12-31) — Other Non Cash Items: 1188310.00
IVF balance_sheet (annual, 2021-12-31) — Other Properties: 2444988.00
IVF income_statement (annual, 2021-12-31) — Other Special Charges: -159126.00
IVF balance_sheet (annual, 2021-12-31) — Payables: 443422.00
IVF balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 443422.00
IVF balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 581689.00
IVF balance_sheet (annual, 2021-12-31) — Prepaid Assets: 282751.00
IVF income_statement (annual, 2021-12-31) — Pretax Income: -6650176.00
IVF cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 369840.00
IVF balance_sheet (annual, 2021-12-31) — Properties: 0.00
IVF cash_flow (annual, 2021-12-31) — Purchase Of Business: -1698863.00
IVF cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -38939.00
IVF cash_flow (annual, 2021-12-31) — Purchase Of PPE: -415710.00
IVF balance_sheet (annual, 2021-12-31) — Raw Materials: 67605.00
IVF balance_sheet (annual, 2021-12-31) — Receivables: 50470.00
IVF income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 145052.00
IVF income_statement (annual, 2021-12-31) — Reconciled Depreciation: 166082.00
IVF cash_flow (annual, 2021-12-31) — Repayment Of Debt: -250000.00
IVF income_statement (annual, 2021-12-31) — Research And Development: 216430.00
IVF balance_sheet (annual, 2021-12-31) — Retained Earnings: -38891022.00
IVF income_statement (annual, 2021-12-31) — Selling General And Administration: 9015158.00
IVF balance_sheet (annual, 2021-12-31) — Share Issued: 414.00
IVF cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
IVF cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -250000.00
IVF income_statement (annual, 2021-12-31) — Special Income Charges: 159126.00
IVF cash_flow (annual, 2021-12-31) — Stock Based Compensation: 2708189.00
IVF balance_sheet (annual, 2021-12-31) — Stockholders Equity: 7310680.00
IVF balance_sheet (annual, 2021-12-31) — Tangible Book Value: 7178587.00
IVF income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 42009.84
IVF income_statement (annual, 2021-12-31) — Tax Provision: 4764.00
IVF income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.27
IVF balance_sheet (annual, 2021-12-31) — Total Assets: 10466380.00
IVF balance_sheet (annual, 2021-12-31) — Total Capitalization: 7310680.00
IVF balance_sheet (annual, 2021-12-31) — Total Debt: 2123550.00
IVF balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 7310680.00
IVF income_statement (annual, 2021-12-31) — Total Expenses: 9376640.00
IVF balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 3155700.00
IVF balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 4160515.00
IVF balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 1902696.00
IVF income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -5216524.00
IVF balance_sheet (annual, 2021-12-31) — Total Tax Payable: 0.00
IVF income_statement (annual, 2021-12-31) — Total Unusual Items: 155592.00
IVF income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 155592.00
IVF balance_sheet (annual, 2021-12-31) — Work In Process: 0.00
IVF balance_sheet (annual, 2021-12-31) — Working Capital: 5052861.00
IVF income_statement (annual, 2022-12-31) — +Operating Expense: 10597907.00
IVF income_statement (annual, 2022-12-31) — +Total Revenue: 822196.00
IVF balance_sheet (annual, 2022-12-31) — Accounts Payable: 1349038.00
IVF balance_sheet (annual, 2022-12-31) — Accounts Receivable: 77149.00
IVF balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -153267.00
IVF balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 48805860.00
IVF cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 132227.00
IVF income_statement (annual, 2022-12-31) — Basic Average Shares: 422.00
IVF income_statement (annual, 2022-12-31) — Basic EPS: -25811.64
IVF cash_flow (annual, 2022-12-31) — Beginning Cash Position: 5684871.00
IVF cash_flow (annual, 2022-12-31) — Capital Expenditure: -12728.00
IVF balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1507648.00
IVF balance_sheet (annual, 2022-12-31) — Capital Stock: 61.00
IVF balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 90135.00
IVF balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 90135.00
IVF balance_sheet (annual, 2022-12-31) — Cash Financial: 90135.00
IVF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1089800.00
IVF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -81217.00
IVF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -6603319.00
IVF cash_flow (annual, 2022-12-31) — Change In Account Payable: 904060.00
IVF cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 366129.00
IVF cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 0.00
IVF cash_flow (annual, 2022-12-31) — Change In Interest Payable: 1556.00
IVF cash_flow (annual, 2022-12-31) — Change In Inventory: 24171.00
IVF cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 7026.00
IVF cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 114786.00
IVF cash_flow (annual, 2022-12-31) — Change In Payable: 904060.00
IVF cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1270189.00
IVF cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 92550.00
IVF cash_flow (annual, 2022-12-31) — Change In Receivables: -26679.00
IVF cash_flow (annual, 2022-12-31) — Change In Tax Payable: 0.00
IVF cash_flow (annual, 2022-12-31) — Change In Working Capital: 1482043.00
IVF cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -26679.00
IVF cash_flow (annual, 2022-12-31) — Changes In Cash: -5594736.00
IVF balance_sheet (annual, 2022-12-31) — Common Stock: 61.00
IVF balance_sheet (annual, 2022-12-31) — Common Stock Equity: -977612.00
IVF cash_flow (annual, 2022-12-31) — Common Stock Issuance: 289800.00
IVF income_statement (annual, 2022-12-31) — Cost Of Revenue: 850770.00
IVF balance_sheet (annual, 2022-12-31) — Current Assets: 621087.00
IVF balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 160185.00
IVF balance_sheet (annual, 2022-12-31) — Current Debt: 762644.00
IVF balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 922829.00
IVF balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 119876.00
IVF balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 119876.00
IVF balance_sheet (annual, 2022-12-31) — Current Liabilities: 3338005.00
IVF balance_sheet (annual, 2022-12-31) — Current Notes Payable: 662644.00
IVF cash_flow (annual, 2022-12-31) — Depreciation: 306319.00
IVF cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 77301.00
IVF income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 77301.00
IVF cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 77301.00
IVF income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 77301.00
IVF income_statement (annual, 2022-12-31) — Diluted Average Shares: 422.00
IVF income_statement (annual, 2022-12-31) — Diluted EPS: -25811.64
IVF income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -10892511.00
IVF income_statement (annual, 2022-12-31) — EBIT: -10830194.00
IVF income_statement (annual, 2022-12-31) — EBITDA: -10752893.00
IVF income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -200558.00
IVF cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 200558.00
IVF cash_flow (annual, 2022-12-31) — End Cash Position: 90135.00
IVF cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1089800.00
IVF balance_sheet (annual, 2022-12-31) — Finished Goods: 194879.00
IVF cash_flow (annual, 2022-12-31) — Free Cash Flow: -6616047.00
IVF income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -3463.00
IVF balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
IVF balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 0.00
IVF balance_sheet (annual, 2022-12-31) — Gross PPE: 2004120.00
IVF income_statement (annual, 2022-12-31) — Gross Profit: -28574.00
IVF cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 800.00
IVF income_statement (annual, 2022-12-31) — Interest Expense: 59445.00
IVF income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 59445.00
IVF income_statement (annual, 2022-12-31) — Interest Income: 308.00
IVF income_statement (annual, 2022-12-31) — Interest Income Non Operating: 308.00
IVF cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
IVF balance_sheet (annual, 2022-12-31) — Inventory: 263602.00
IVF balance_sheet (annual, 2022-12-31) — Invested Capital: -214968.00
IVF cash_flow (annual, 2022-12-31) — Investing Cash Flow: -81217.00
IVF balance_sheet (annual, 2022-12-31) — Investments And Advances: 1237865.00
IVF balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 1237865.00
IVF balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 0.00
IVF cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 289800.00
IVF cash_flow (annual, 2022-12-31) — Issuance Of Debt: 800000.00
IVF balance_sheet (annual, 2022-12-31) — Leases: 96817.00
IVF balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1347463.00
IVF balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1347463.00
IVF cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 800000.00